文献速递神经免疫

外泌体转录组分析揭示多发性硬化生物标志物

Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.
PubMed 文献 · Ann Neurol · 2017-01-01

研究对19例复发缓解型多发性硬化患者和10名健康对照的血清外泌体进行RNA测序,发现4个miRNA在患者中差异表达,并在独立验证队列中确认其在复发期显著降低,或可作为区分复发的生物标志物。

要点

  • 复发缓解型多发性硬化患者血清外泌体miRNA谱与健康对照不同。
  • hsa-miR-122-5p等4个miRNA在复发期显著降低,或可区分复发。
  • 这些miRNA在脑MRI钆增强患者中也降低。

核心结论

  • 复发缓解型多发性硬化患者循环外泌体具有独特的RNA谱,外泌体miRNA或可作为区分复发的生物标志物。

研究设计与样本

  • 研究采用下一代测序定义19例复发缓解型多发性硬化患者(9例复发期、10例缓解期)和10名健康对照的血清外泌体全局RNA谱,每样本分析500万reads和超过5万个转录本。
  • 发现集数据通过数字定量PCR在独立队列中验证,该队列包括63例复发缓解型多发性硬化患者(33例复发期、30例缓解期)和32名健康对照。

主要发现

  • 在检测到的15类转录本中,miRNA类别内有4个循环外泌体序列在复发缓解型多发性硬化患者与健康对照间差异表达:hsa-miR-122-5p、hsa-miR-196b-5p、hsa-miR-301a-3p和hsa-miR-532-5p。
  • 这些miRNA的血清外泌体表达在复发缓解型多发性硬化复发期显著降低。
  • 这些miRNA在脑磁共振成像显示钆增强的患者中也降低。
  • 这些miRNA由外周血单核细胞的体外分泌在复发缓解型多发性硬化中也显著受损。

临床怎么用

  • 外泌体miRNA可能有助于区分多发性硬化复发,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Accumulating evidence supports a role for exosomes in immune regulation. In this study, we investigated the total circulating exosome transcriptome in relapsing-remitting multiple sclerosis (RRMS) patients and healthy controls (HC). METHODS: Next generation sequencing (NGS) was used to define the global RNA profile of serum exosomes in 19 RRMS patients (9 in relapse, 10 in remission) and 10 HC. We analyzed 5 million reads and >50,000 transcripts per sample, including a detailed analysis of microRNAs (miRNAs) differentially expressed in RRMS. The discovery set data were validated by quantification using digital quantitative polymerase chain reaction with an independent cohort of 63 RRMS patients (33 in relapse, 30 in remission) and 32 HC. RESULTS: Exosomal RNA NGS revealed that of 15 different classes of transcripts detected, 4 circulating exosomal sequences within the miRNA category were differentially expressed in RRMS patients versus HC: hsa-miR-122-5p, hsa-miR-196b-5p, hsa-miR-301a-3p, and hsa-miR-532-5p. Serum exosomal expression of these miRNAs was significantly decreased during relapse in RRMS. These miRNAs were also decreased in patients with a gadolinium enhancement on brain magnetic resonance imaging. In vitro secretion of these miRNAs by peripheral blood mononuclear cells was also significantly impaired in RRMS. INTERPRETATION: These data show that circulating exosomes have a distinct RNA profile in RRMS. Because putative targets for these miRNAs include the signal transducer and activator of transcription 3 and the cell cycle regulator aryl hydrocarbon receptor, the data suggest a disturbed cell-to-cell communication in this disease. Thus, exosomal miRNAs might represent a useful biomarker to distinguish multiple sclerosis relapse. Ann Neurol 2017;81:703-717.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Selmaj I, Cichalewska M, Namiecinska M, et al. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol. 2017. PMID: 28411393. doi:10.1002/ana.24931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。